Bionano Genomics, Inc. Operating Income
Bionano Genomics, Inc. (BNGO) reported Operating Income of -$7.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- Bionano Genomics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$7.22M.
- Bionano Genomics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$7.90M.
- Bionano Genomics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$8.54M.
- Bionano Genomics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$8.54M.
- Bionano Genomics, Inc. operating income (loss) for fiscal 2025 was -$33.34M.
- Bionano Genomics, Inc. operating income (loss) for fiscal 2024 was -$103.98M.
- Bionano Genomics, Inc. operating income (loss) for fiscal 2023 was -$215.25M.
- Bionano Genomics, Inc. operating income (loss) for fiscal 2022 was -$131.70M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$7.22M 10-Q · filed 2026-08-10 | -$15.12M 10-Q · filed 2026-08-10 | -$23.65M derived: sum of 3 quarters · filed 2026-08-10 | -$32.19M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$7.90M 10-Q · filed 2026-05-13 | -$16.43M derived: sum of 2 quarters · filed 2026-05-13 | -$24.97M derived: sum of 3 quarters · filed 2026-05-13 | -$32.77M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$8.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$17.07M derived: sum of 2 quarters · filed 2026-03-23 | -$24.87M derived: sum of 3 quarters · filed 2026-08-10 | -$33.34M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$8.54M 10-Q · filed 2025-11-13 | -$16.34M derived: sum of 2 quarters · filed 2026-08-10 | -$24.80M 10-Q · filed 2025-11-13 | -$36.74M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$7.80M 10-Q · filed 2026-08-10 | -$16.26M 10-Q · filed 2026-08-10 | -$28.21M derived: sum of 3 quarters · filed 2026-08-10 | -$72.11M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$8.46M 10-Q · filed 2026-05-13 | -$20.41M derived: sum of 2 quarters · filed 2026-05-13 | -$64.31M derived: sum of 3 quarters · filed 2026-05-13 | -$81.33M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$11.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$55.84M derived: sum of 2 quarters · filed 2026-03-23 | -$72.86M derived: sum of 3 quarters · filed 2026-03-23 | -$103.98M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | -$43.90M 10-Q · filed 2025-11-13 | -$60.92M derived: sum of 2 quarters · filed 2025-11-13 | -$92.04M 10-Q · filed 2025-11-13 | -$117.00M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$17.02M 10-Q · filed 2025-08-14 | -$48.14M 10-Q · filed 2025-08-14 | -$73.09M derived: sum of 3 quarters · filed 2025-08-14 | -$186.31M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$31.12M 10-Q · filed 2025-05-14 | -$56.08M derived: sum of 2 quarters · filed 2025-05-14 | -$169.29M derived: sum of 3 quarters · filed 2025-05-14 | -$208.53M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | -$24.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$138.16M derived: sum of 2 quarters · filed 2025-03-31 | -$177.40M derived: sum of 3 quarters · filed 2025-03-31 | -$215.25M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$113.21M 10-Q · filed 2024-11-14 | -$152.45M derived: sum of 2 quarters · filed 2024-11-14 | -$190.29M 10-Q · filed 2024-11-14 | -$227.82M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$39.24M 10-Q · filed 2024-08-07 | -$77.08M 10-Q · filed 2024-08-07 | -$114.61M derived: sum of 3 quarters · filed 2024-08-07 | -$146.76M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$37.84M 10-Q · filed 2024-05-08 | -$75.37M derived: sum of 2 quarters · filed 2024-05-08 | -$107.52M derived: sum of 3 quarters · filed 2024-05-08 | -$139.60M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$37.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$69.68M derived: sum of 2 quarters · filed 2024-03-05 | -$101.75M derived: sum of 3 quarters · filed 2024-03-05 | -$131.70M 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | -$32.15M 10-Q · filed 2023-11-08 | -$64.23M derived: sum of 2 quarters · filed 2023-11-08 | -$94.17M 10-Q · filed 2023-11-08 | -$122.95M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$32.08M 10-Q · filed 2023-08-09 | -$62.02M 10-Q · filed 2023-08-09 | -$90.81M derived: sum of 3 quarters · filed 2023-08-09 | -$111.48M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$29.94M 10-Q · filed 2023-05-09 | -$58.73M derived: sum of 2 quarters · filed 2023-05-09 | -$79.40M derived: sum of 3 quarters · filed 2023-05-09 | -$95.88M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$28.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$49.46M derived: sum of 2 quarters · filed 2023-03-09 | -$65.94M derived: sum of 3 quarters · filed 2023-03-09 | -$77.10M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$20.68M 10-Q · filed 2022-11-03 | -$37.15M derived: sum of 2 quarters · filed 2022-11-03 | -$48.32M 10-Q · filed 2022-11-03 | -$59.44M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$16.48M 10-Q · filed 2022-08-04 | -$27.64M 10-Q · filed 2022-08-04 | -$38.77M derived: sum of 3 quarters · filed 2022-08-04 | -$48.99M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$11.16M 10-Q · filed 2022-05-05 | -$22.29M derived: sum of 2 quarters · filed 2022-05-05 | -$32.52M derived: sum of 3 quarters · filed 2022-05-05 | -$39.95M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | -$11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$21.35M derived: sum of 2 quarters · filed 2022-03-01 | -$28.79M derived: sum of 3 quarters · filed 2022-03-01 | -$38.55M 10-K · filed 2022-03-01 | -$38.55M 10-K · filed 2021-03-23 | |||
| 2020-09-30 | -$10.23M 10-Q · filed 2021-11-04 | -$17.66M derived: sum of 2 quarters · filed 2021-11-04 | -$27.43M 10-Q · filed 2021-11-04 | -$34.58M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$7.43M 10-Q · filed 2021-08-04 | -$17.20M 10-Q · filed 2021-08-04 | -$24.36M derived: sum of 3 quarters · filed 2021-08-04 | -$30.04M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2020-03-31 | -$9.76M 10-Q · filed 2021-05-13 | -$16.92M derived: sum of 2 quarters · filed 2021-05-13 | -$22.61M derived: sum of 3 quarters · filed 2021-05-13 | -$29.45M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$12.85M derived: sum of 2 quarters · filed 2021-03-23 | -$19.69M derived: sum of 3 quarters · filed 2021-03-23 | -$25.87M 10-K · filed 2021-03-23 | ||||
| 2019-09-30 | -$5.68M 10-Q · filed 2020-11-13 | -$5.69M 10-Q · filed 2019-11-07 | -$12.53M derived: sum of 2 quarters · filed 2020-11-13 | -$18.71M 10-Q · filed 2020-11-13 | -$18.71M 10-Q · filed 2019-11-07 | -$24.81M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | -$6.84M 10-Q · filed 2020-08-13 | -$6.84M 10-Q · filed 2019-08-08 | -$13.03M 10-Q · filed 2020-08-13 | -$13.03M 10-Q · filed 2019-08-08 | -$19.13M derived: sum of 3 quarters · filed 2020-08-13 | -$25.10M derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | -$6.18M 10-Q · filed 2020-06-18 | -$6.19M 10-Q · filed 2019-05-09 | -$12.28M derived: sum of 2 quarters · filed 2020-06-18 | -$18.25M derived: sum of 3 quarters · filed 2020-06-18 | -$22.26M derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$12.07M derived: sum of 2 quarters · filed 2020-03-10 | -$16.08M derived: sum of 3 quarters · filed 2020-03-10 | -$20.42M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | -$5.97M 10-Q · filed 2019-11-07 | -$9.98M derived: sum of 2 quarters · filed 2019-11-07 | -$14.32M 10-Q · filed 2019-11-07 | -$19.56M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$4.01M 10-Q · filed 2019-08-08 | -$8.35M 10-Q · filed 2019-08-08 | -$13.59M derived: sum of 3 quarters · filed 2019-08-08 | -$18.62M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$4.34M 10-Q · filed 2019-05-09 | -$9.57M derived: sum of 2 quarters · filed 2019-05-09 | -$14.61M derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | -$5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$10.27M derived: sum of 2 quarters · filed 2019-03-14 | -$23.22M 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | -$5.03M 10-Q · filed 2018-11-07 | -$17.98M 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |